HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

arginyl-glycyl-aspartyl-cysteine

structure in first source

Also Known As:

Arg-Gly-Asp-Cys; RGDC peptide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Oligopeptides: 519
    - arginyl-glycyl-aspartyl-cysteine: 2

Experts

1.	Ai, Kelong: 1 article (01/2017)
2.	Chen, Xuesi: 1 article (01/2017)
3.	Jiang, Chunhuan: 1 article (01/2017)
4.	Li, Yuanyuan: 1 article (01/2017)
5.	Lu, Lehui: 1 article (01/2017)
6.	Ren, Xiaoyan: 1 article (01/2017)
7.	Wang, Ying: 1 article (01/2017)
8.	Zhang, Dawei: 1 article (01/2017)
9.	Chen, Hongmin: 1 article (06/2013)
10.	Chen, Xiaoyuan: 1 article (06/2013)

Related Diseases

1.

Neoplasms (Cancer)

01/01/2017 - "RGDC peptide modified PDAs can improve the PA imaging and PTT efficiency and specific targeted deliver doxorubicin (DOX) to perinuclear region of tumor cells. "
06/25/2013 - "Recently, we demonstrated that Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys (RGD4C)-modified ferritin can efficiently home to tumors through RGD-integrin αvβ3 interaction. "
01/01/2017 - "Upon modification with arginine-glycine-aspartic-cysteine acid (RGDC) peptide, PDA-RGDC can successfully target tumor site. "

Related Drugs and Biologics

1.	Integrins
2.	Glycine (Aminoacetic Acid)
3.	Ferritins (Ferritin)
4.	Doxorubicin (Adriamycin)
5.	Cysteine (L-Cysteine)
6.	Arginine (L-Arginine)
7.	Acids